Stryker 2018 net sales up 9.3% to $413.6B, spine jumps 18%: 5 things to know

Written by Laura Dyrda | January 29, 2019 | Print  |

Stryker's 2018 sales increased 9.3 percent to $413.6 billion, with growth across all lines.

 Five things to know:

1. Fourth quarter sales increased 9.4 percent to $3.8 billion. The breakdown of sales across business lines include:

• Orthopedics: 5.4 percent increase to hit $1.4 billion
• Medsurg: 8.9 percent increase to hit $1.7 billion
• Spine: 19.5 percent increase to hit $700 million

2. The breakdown of full year business line sales include:

• Orthopedics: 5.9 percent increase to hit $5 billion
• Medsurg: 8.8 percent increase to hit $6 billion
• Spine: 18 percent increase to hit $2.6 billion

"Our multi-year momentum reflects the strength of our diversified model, progress on globalization and outstanding people and culture," said CEO Kevin Lobo. "We are well positioned to deliver for our customers, employees and shareholders in 2019 and beyond."

3. U.S. sales increased 10.1 percent in the fourth quarter and 8.7 percent for the full year. International sales were up 7.3 percent for the fourth quarter and 10.9 percent for the full year.

4. Within the orthopedics line, knee and trauma sales drove growth. Knee sales were up 6.6 percent to $1.7 billion, while trauma and extremities sales were up 6.9 percent to $1.5 billion. Hip sales increased 2.5 percent to $1.3 billion.

5. For 2019, the company expects organic net sales to grow 6.5 percent to 7.5 percent and adjusted net earnings per share to hit $8.00 to $8.20.

More articles on orthopedic devices:
Spine surgery robots market to reach $320M by 2026—Who holds 80% of the market?
SpineGuard reports 7% drop in 2018 revenue: 5 details
How China-US tariff tension affects orthopedic companies; Moody's thinks they'll adapt

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months